UnitedHealth Group Incorporated’s EV / EBITDA at a glance
UnitedHealth Group Incorporated reports ev / ebitda of 18.6x for Dec 2024. The prior period recorded 14.6x (Dec 2023). Year over year the metric moved +3.97 (+27.2%). The rolling three-period average stands at 16.6x. Data last refreshed Nov 20, 2025, 1:26 PM.
Latest reading
18.6x · Dec 2024
YoY movement
+3.97 (+27.2%)
Rolling average
16.6x
Current EV / EBITDA
18.6x
+3.97
+27.2%
Rolling average
16.6x
Latest Value
18.6x
Dec 2024
YoY Change
+3.97
Absolute
YoY Change %
+27.2%
Rate of change
3-Period Avg
16.6x
Smoothed
Narrative signal
UnitedHealth Group Incorporated’s ev / ebitda stands at 18.6x for Dec 2024. Year-over-year, the metric shifted by +3.97, translating into a +27.2% rate of change versus the prior period.
Pair this momentum with product cadence, pricing power, and capital allocation moves to understand durability.
Blend with balance sheet, cash flow, and peer benchmarks from AlphaPilot’s broader dashboards to shape an investable thesis.
How ev / ebitda shapes UnitedHealth Group Incorporated's story
As of Dec 2024, UnitedHealth Group Incorporated reports ev / ebitda of 18.6x. Use EV/EBITDA to benchmark acquisition multiples, leverage-adjusted valuation, and comparable transaction ranges.
Why EV/EBITDA matters
It normalizes valuation across different leverage levels, making it a go-to metric for M&A and cross-company comparisons.
Watch for cyclical swings
EBITDA can swing with cycle-sensitive businesses. Track multi-year averages and peak vs. trough to understand value ranges.
Valuation Multiples
Compare how the market prices revenue, equity, and operating cash flow versus peers and history.
Profitability & Margins
Understand cost structure and capital efficiency trends across gross, operating, and net results.
Gross Margin
22.3%
Operating Margin
8.1%
Net Profit Margin
3.6%
Return on Equity
15.5%
Return on Assets
4.8%
Growth Momentum
Track whether top-line, earnings, and free cash flow growth are accelerating or cooling.
Balance Sheet Strength
Evaluate leverage, liquidity, and cash generation capacity that underpin resilience.
Shareholder Returns
Follow dividend sustainability and cash generation relative to market value.
UnitedHealth Group Incorporated (UNH) FAQs
Answers tailored to UnitedHealth Group Incorporated’s ev / ebitda profile using the latest Financial Modeling Prep data.
What is UnitedHealth Group Incorporated's current ev / ebitda?
As of Dec 2024, UnitedHealth Group Incorporated reports ev / ebitda of 18.6x. This reading reflects the latest filings and price data for UNH.
How is UnitedHealth Group Incorporated's ev / ebitda trending year over year?
Year-over-year, the figure shifts by +3.97 (+27.2%). Pair this context with revenue growth and free cash flow signals to gauge momentum for UNH.
Why does ev / ebitda matter for UnitedHealth Group Incorporated?
The enterprise value to EBITDA ratio evaluates valuation relative to operating cash flow before capital structure impacts. For UnitedHealth Group Incorporated, operating within Healthcare — Medical - Healthcare Plans, tracking this metric helps benchmark management's execution against close competitors.
Is UnitedHealth Group Incorporated's ev / ebitda above its recent average?
UnitedHealth Group Incorporated's rolling three-period average sits at 16.6x. Comparing the latest reading of 18.6x to that baseline highlights whether momentum is building or fading for UNH.
How frequently is UnitedHealth Group Incorporated's ev / ebitda refreshed?
Data for UNH was last refreshed on Nov 20, 2025, 1:26 PM and updates automatically every 24 hours, keeping your valuation inputs current.